Vulvovaginal Candidiasis

Vulvovaginal Candidiasis is the indication for 11 drugs in DrugBank. It is covered by 12 curated, structured indications.

Also known as: Candidiasis, Vulvovaginal · Vulvo-vaginal Candidiasis · Vulvovaginal Candidiases · Vulvovaginal Candidiasis (VVC) · Vulvovaginal Candidiasis, Genital
Classified under: Infections
Urogenital Diseases
Indicated drugs: Butoconazole
Ciclopirox
Ibrexafungerp
Itraconazole
Ketoconazole
Lidocaine
Nystatin
Sertaconazole
Sulfanilamide
Terconazole
Tioconazole

Resolves to

Vocabularies

MeSHM0003262ICD-10B37.3SNOMED CT154404004MedDRA10007164UMLSC0700345

What you can answer from here — as of October 20, 2026

11Indicated drugsWith each drug's targets and mechanism

Listed above

12Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

70Clinical trialsPhase, status and sponsor resolved per trial

19Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Vulvovaginal Candidiasis share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.